1 From the Department of Neurology (A.H., L.K., A.A.K., C.L.), Charité-University Medicine (CVK), Berlin, Germany; Movement Disorders Unit (A.H., A.A.K.), Charité-University Medicine (CVK), Berlin, Germany; Berenson-Allen Center for Noninvasive Brain Stimulation (A.H.), Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Department of Neurosurgery (A.M.), Brigham and Women's Hospital, Boston, MA; NeuroCure-Cluster of Excellence (A.A.K.); Berlin School of Mind and Brain (A.A.K.); and Deutsches Zentrum für Neurodegenerative Erkrankungen (A.A.K.), Berlin, Germany. andreas.horn@charite.de.
2 From the Department of Neurology (A.H., L.K., A.A.K., C.L.), Charité-University Medicine (CVK), Berlin, Germany; Movement Disorders Unit (A.H., A.A.K.), Charité-University Medicine (CVK), Berlin, Germany; Berenson-Allen Center for Noninvasive Brain Stimulation (A.H.), Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Department of Neurosurgery (A.M.), Brigham and Women's Hospital, Boston, MA; NeuroCure-Cluster of Excellence (A.A.K.); Berlin School of Mind and Brain (A.A.K.); and Deutsches Zentrum für Neurodegenerative Erkrankungen (A.A.K.), Berlin, Germany.